125 related articles for article (PubMed ID: 12740756)
41. Obsessional symptoms associated with risperidone treatment.
Mahendran R
Aust N Z J Psychiatry; 1998 Apr; 32(2):299-301. PubMed ID: 9588312
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients.
Allan ER; Alpert M; Sison CE; Citrome L; Laury G; Berman I
J Clin Psychiatry; 1996 Oct; 57(10):455-9. PubMed ID: 8909331
[TBL] [Abstract][Full Text] [Related]
43. Risperidone treatment of schizophrenia: improvement in psychopathology and neuropsychological tests.
Borkowska A; Araszkiewicz A; Rajewski A; Rybakowski JK
Neuropsychobiology; 2002; 46(2):85-9. PubMed ID: 12378125
[TBL] [Abstract][Full Text] [Related]
44. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials.
Aleman A; Kahn RS
Eur Neuropsychopharmacol; 2001 Aug; 11(4):289-93. PubMed ID: 11532383
[TBL] [Abstract][Full Text] [Related]
45. [Identification of subgroups of schizophrenic patients by a typological analysis].
Dollfus S; Everitt B; Petit M
Ann Med Psychol (Paris); 1995 Oct; 153(8):517-20; discussion 520-1. PubMed ID: 8561396
[TBL] [Abstract][Full Text] [Related]
46. [Risperidone: a real alternative for patients treated with depot neuroleptics].
Bobes J; González MP; Sáiz PA; Octavio I; Fernández JM; Bousoño M
Actas Esp Psiquiatr; 2000; 28(6):367-72. PubMed ID: 11262281
[TBL] [Abstract][Full Text] [Related]
47. [Schizophrenic excitement and the role of lithium in its therapy (apropos of 2 recent cases)].
Skurnik N; Shalev A; Munitz H; Tyano S
Ann Med Psychol (Paris); 1985 Dec; 143(10):960-2. PubMed ID: 2873776
[No Abstract] [Full Text] [Related]
48. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia.
Zhang XY; Zhou DF; Yuan CL; Zhang PY; Wu GY; Shen YC
Psychiatry Res; 2002 Apr; 109(3):297-302. PubMed ID: 11959366
[TBL] [Abstract][Full Text] [Related]
49. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
Maneeton N; Intaprasert S; Srisurapanont M
J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
[TBL] [Abstract][Full Text] [Related]
50. The use of midazolam in acutely agitated psychiatric patients.
Wyant M; Diamond BI; O'Neal E; Sloan A; Borison RL
Psychopharmacol Bull; 1990; 26(1):126-9. PubMed ID: 2371367
[TBL] [Abstract][Full Text] [Related]
51. Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics.
Lane HY; Chang YC; Chiu CC; Chen TT; Lee SH; Chang WH
J Clin Psychopharmacol; 2002 Aug; 22(4):353-8. PubMed ID: 12172333
[TBL] [Abstract][Full Text] [Related]
52. [Respiratory effects of risperidone? A prospective study].
Touraine F; Antonini MT; Bourlot D; Trarieux AM; Dalmay F; Bonnaud F; Lombertie E
Rev Pneumol Clin; 2003 Feb; 59(1):33-7. PubMed ID: 12717324
[TBL] [Abstract][Full Text] [Related]
53. A case of agitated catatonia.
Cottencin O; Thomas P; Vaiva G; Rascle C; Goudemand M
Pharmacopsychiatry; 1999 Jan; 32(1):38-40. PubMed ID: 10071181
[TBL] [Abstract][Full Text] [Related]
54. A syndrome of increased affect in response to risperidone among patients with schizophrenia.
Ashleigh EA; Larsen PD
Psychiatr Serv; 1998 Apr; 49(4):526-8. PubMed ID: 9550246
[TBL] [Abstract][Full Text] [Related]
55. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.
Smelson DA; Losonczy MF; Davis CW; Kaune M; Williams J; Ziedonis D
Can J Psychiatry; 2002 Sep; 47(7):671-5. PubMed ID: 12355680
[TBL] [Abstract][Full Text] [Related]
56. [3 years of risperidone: from innovation to example].
Nervenarzt; 1997 Apr; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
[No Abstract] [Full Text] [Related]
57. Can risperidone reduce cocaine use in substance abusing schizophrenic patients?
Tsuang JW; Eckman T; Marder S; Tucker D
J Clin Psychopharmacol; 2002 Dec; 22(6):629-30. PubMed ID: 12454567
[No Abstract] [Full Text] [Related]
58. [Visual and motor functions in schizophrenic patients].
Del Vecchio S; Gargiulo PA
Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):317-22. PubMed ID: 1364126
[TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia].
Costa JG; Silva E; Dreyfus JF
Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086
[TBL] [Abstract][Full Text] [Related]
60. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
